Advertisement
Home »

Efficacy and safety of eptinezumab in patients with chronic migraine and medication-overuse headache: a randomized, double-blind, placebo-controlled study.

Dec 18, 2023

ABOUT THE EXPERTS

  • Shengyuan Yu

    Department of Neurology, Chinese PLA General Hospital, Beijing, China. yusy1963@126.com.

    Jiying Zhou

    Department of Neurology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.

    Guogang Luo

    Neurology Department, The First Affiliated Hospital of Xi’an Jiaotong University, Xi’an, China.

    Zheman Xiao

    Department of Neurology, Renmin Hospital of Wuhan University, Wuhan, China.

    Anders Ettrup

    H. Lundbeck A/S, Copenhagen, Denmark.

    Gary Jansson

    H. Lundbeck A/S, Copenhagen, Denmark.

    Ioana Florea

    H. Lundbeck A/S, Copenhagen, Denmark.

    Kristina Ranc

    H. Lundbeck A/S, Copenhagen, Denmark.

    Patricia Pozo-Rosich

    Neurology Department, Headache Unit, Vall d’Hebron University Hospital, Barcelona, Spain.

    Headache and Neurological Pain Research Group, Vall d’Hebron Research Institute, Department de Medicina, Universitat Autonoma de Barcelona, Barcelona, Spain.

REFERENCES & ADDITIONAL READING

PubMed

MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.


Advertisement
Advertisement
ad
ad
MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.

SUBSCRIBE NOW

View all newsletters

Advertisement